d/b/a "PCAI Pharma" ( and its wholly-owned subsidiary AI Pharmaceuticals Jamaica Limited, a private corporation incorporated and operating under the laws of Jamaica. Additionally, the Company recently acquired 1196691 B.C. (formerly, Osoyoos Cannabis Inc.) has a joint-venture agreement with a private, vertically-integrated licensed producer under the Cannabis Act (Canada) to offer contract tolling extraction services to third-party businesses. "The technology assembled under the Aion banner is unparalleled in my estimation and I am looking forward to working with this team and helping officiate this tremendous opportunity."Īion Therapeutic Inc. "I am thrilled to join the talented team at Aion," stated Dr. "His expertise directly aligns with our intentions and his practical business expertise and relationships are accretive to Aion's interests." Thompson's accomplishments, experience and skill-set makes him an ideal selection as our new president," stated Dr.
Thompson's work specializes in the research, development, application, market strategy and commercialization of biotech and he is a principal inventor on 13 awarded patents and 3 pending patents related to data analytics, remote database systems, medical hardware, medical software and neuromodulation. He has led early and mid-stage companies in multiple verticals including mental health, brain injury, neuro-degeneration, cardiology and wellness, covering medical devices, software, clinical research, therapeutics, regulatory, AI and big data.ĭr. Thompson served on the Board of Directors for 10 years and held roles as Chief Science Officer, Chief Technology Officer and Chief Innovation Officer. Most recently he co-founded Evoke Neuroscience, Inc., a healthcare technology company founded in 2009 and focused on aiding diagnosis and therapy for neurological disorders. Thompson is an accomplished neuroscientist and healthcare technology entrepreneur with over 20 years industry experience. (CSE: AION) (" Aion Therapeutic" or the " Company") is pleased to announce that the Company has named James W.G. October 21, 2020) - Aion Therapeutic Inc. Neuroscientist, Healthcare Technology Entrepreneur to Lead Aion Through Important Next Phase
0 kommentar(er)
